HYDROCHLOROTHIAZIDE W/ RESERPINE Drug Patent Profile

✉ Email this page to a colleague

When do Hydrochlorothiazide W/ Reserpine patents expire, and when can generic versions of Hydrochlorothiazide W/ Reserpine launch?

Hydrochlorothiazide W/ Reserpine is a drug marketed by Ivax Sub Teva Pharms, Pharmeral, Roxane, and Watson Labs. and is included in fourteen NDAs.

The generic ingredient in HYDROCHLOROTHIAZIDE W/ RESERPINE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for HYDROCHLOROTHIAZIDE W/ RESERPINE?
What are the global sales for HYDROCHLOROTHIAZIDE W/ RESERPINE?
What is Average Wholesale Price for HYDROCHLOROTHIAZIDE W/ RESERPINE?

Summary for HYDROCHLOROTHIAZIDE W/ RESERPINE

US Patents:	0
Applicants:	4
NDAs:	14
Raw Ingredient (Bulk) Api Vendors:	84
Clinical Trials:	2
DailyMed Link:	HYDROCHLOROTHIAZIDE W/ RESERPINE at DailyMed

Drug patent expirations by year for HYDROCHLOROTHIAZIDE W/ RESERPINE

Recent Clinical Trials for HYDROCHLOROTHIAZIDE W/ RESERPINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
West China Hospital	Phase 4
VA Office of Research and Development
US Department of Veterans Affairs

See all HYDROCHLOROTHIAZIDE W/ RESERPINE clinical trials

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE W/ RESERPINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ivax Sub Teva Pharms	HYDROCHLOROTHIAZIDE W/ RESERPINE	hydrochlorothiazide; reserpine	TABLET;ORAL	083572-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Roxane	HYDROCHLOROTHIAZIDE W/ RESERPINE	hydrochlorothiazide; reserpine	TABLET;ORAL	084603-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Sub Teva Pharms	HYDROCHLOROTHIAZIDE W/ RESERPINE	hydrochlorothiazide; reserpine	TABLET;ORAL	083573-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	HYDROCHLOROTHIAZIDE W/ RESERPINE	hydrochlorothiazide; reserpine	TABLET;ORAL	084467-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	HYDROCHLOROTHIAZIDE W/ RESERPINE	hydrochlorothiazide; reserpine	TABLET;ORAL	084466-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	083770-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Sub Teva Pharms	HYDROCHLOROTHIAZIDE W/ RESERPINE	hydrochlorothiazide; reserpine	TABLET;ORAL	083571-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

AI Research Assistant

Questions you can ask:

Summary for HYDROCHLOROTHIAZIDE W/ RESERPINE

Recent Clinical Trials for HYDROCHLOROTHIAZIDE W/ RESERPINE

Make Better Decisions: Try a trial or see plans & pricing